Join us for a must-attend #webinar at 2 PM EST on Feb 13th on optimizing #CDMO selection for #biologics development, featuring strategic insights and practical decision-making tools. Perfect for those in or planning CDMO selection. Register here: bit.ly/4aXA2pB

Partnering with an emerging biotech firm, we've pioneered non-hallucinogenic psychedelic derivatives for mental health. Our expertise in biologics and CMC processes led to new IPs and innovative solutions. Learn more: bit.ly/49d0N7L #Biotech #CMC

Join us on Feb 13, 2024, for insights from these industry leaders. Register now: bit.ly/4aXA2pB #CDMO #Biologics

This Feb, we celebrate #BlackHistoryMonth. It's a time to honor the pivotal role of Black individuals in science, healthcare, and our communities. Diversity fuels innovation in biopharma. We're committed to equality and opportunity in our field, now and always.

In January, the local Making an Impact (MAI) group in RTP demonstrated our commitment to benevolence by writing Valentine’s Day cards to our service members and veterans. 56 cards were mailed and will be distributed worldwide! bit.ly/2FjYXa6 #weinspire #bebenevolent

Embarking on your first regulatory submission? Our experts share invaluable insights from years of guiding #biotech & #pharma teams through NDA, BLA, MAA processes. Discover essential advice for a successful first submission: bit.ly/3OenOz2 #MedicalWriting

We celebrate #BlackHistoryMonth and honor African American scientists & healthcare pros for their pioneering contributions to biopharma. Their work is vital in advancing research & patient care. bit.ly/3xIYKYq #DiversityInScience #Innovation

Excited to be a finalist in Ragan's Employee Communications Awards 2024! Our "Inspiring News" & "Morning Brew" initiatives are bringing our team closer. A big thank you to everyone who's been part of this journey. Details: bit.ly/3wbuwja #OneTeam #WeInspire

Olivia Rivera, PhD, & Yael-Natalie Escobar, PhD, reveal how #medicalwriting thrives in a remote world. Discover the seamless fit of #regulatorywriting, challenges, and success strategies with Syner-G BioPharma Group. Read more: bit.ly/43L5TGN

Jump into the fast lane with Syner-G BioPharma's white paper on accelerated CMC development. We explore the urgent need for speed in #CMC processes without compromising safety or quality. Read the full white paper: bit.ly/4aL9iYw

Why choose #Australia for #clinicaltrials? With a streamlined TGA process and the CTN scheme, trials start in 6-12 weeks. Coupled with high standards like GCP and ICH E6, diverse demographics, and significant incentives, it's ideal for drug development. bit.ly/4aRdm9B

Meet Ray Forslund, Ph.D., the visionary behind 50+ IND approvals. His strategic acumen and technical mastery exemplify excellence in pharma. Discover Ray's story: bit.ly/3DtZgMP Connect with us: bit.ly/3XHwjX9 #CMCLeadership #InnovationInPharma

Syner-G Spotlight: Donna M Little, Senior Director of Regulatory Strategy, with over 29 years in CMC, nonclinical, and clinical regulatory fields. Her role integrates global standards into programs. Learn more: bit.ly/3DtZgMP

Syner-G Spotlight: Timothy Reinhardt, VP of Quality & Compliance. Tim oversees QMS, GxP audits, and GxP vendor management, specializing in products from small molecules to gene therapy. Learn more about Tim: bit.ly/3DtZgMP

The #pharmaceutical industry is set for a major leap with #eCTD 4.0, enhancing efficiency and flexibility in #regulatory submissions worldwide. Our latest blog by Jeff Golden explores how this new version will streamline processes and improve outcomes: bit.ly/3RIZmYu

Explore critical aspects of formulation and analytical considerations in preclinical and early-phase pharmaceutical development. Watch on-demand now: bit.ly/3xG0Pb1 #PharmaceuticalDevelopment #Biotech #Webinar

Explore the intricacies of clinical study protocols with our latest blog. Gain valuable insights and tips for developing effective protocols. Essential reading for medical writers and clinical researchers. Read now: bit.ly/4eCSCVO #MedicalWriting

Today we celebrate the spirit of independence and wish you a joyful and safe July 4th! #4thOfJuly #IndependenceDay

The biopharma landscape is evolving. Our recent blog explores the transition from ICH Q2(R1) to Q2(R2) and ICH Q14 in method validation and development. Learn how these updates enhance robustness & flexibility in drug development:bit.ly/3ZpTVSH #Biopharma

The RAPS Convergence 2024 kicks off today in Long Beach, CA. Syner-G BioPharma Group is proud to be in attendance. If you're attending, connect with us! Event Info: bit.ly/4e17ts7 #RAPSConvergence2024 #RegulatoryAffairs #Biopharma